(Q39110336)

English

NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin

scientific article published on February 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 September 2017

NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin (English)

1 reference

Europe PubMed Central

9 September 2017

1 reference

ChEBI release 2020-05-28

inflammasome complex

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

author name string

Mamoru Satoh

1

1 reference

Europe PubMed Central

9 September 2017

Tsuyoshi Tabuchi

2

1 reference

Europe PubMed Central

9 September 2017

Tomonori Itoh

3

1 reference

Europe PubMed Central

9 September 2017

Motoyuki Nakamura

4

1 reference

Europe PubMed Central

9 September 2017

language of work or name

0 references

publication date

1 February 2014

1 reference

Europe PubMed Central

9 September 2017

Clinical Science

1 reference

Europe PubMed Central

9 September 2017

126

1 reference

Europe PubMed Central

9 September 2017

3

1 reference

Europe PubMed Central

9 September 2017

233-241

1 reference

Europe PubMed Central

9 September 2017

Inflammation in atherosclerosis

1 reference

https://api.crossref.org/works/10.1042%2FCS20130043

21 January 2018

ApoE controls the interface linking lipids and inflammation in atherosclerosis

1 reference

https://api.crossref.org/works/10.1042%2FCS20130043

21 January 2018

Role of Toll like receptor signaling pathway in ischemic coronary artery disease

1 reference

https://api.crossref.org/works/10.1042%2FCS20130043

21 January 2018

Interleukin-18 predicts atherosclerosis progression in SIV-infected and uninfected rhesus monkeys (Macaca mulatta) on a high-fat/high-cholesterol diet

1 reference

https://api.crossref.org/works/10.1042%2FCS20130043

21 January 2018

Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina

1 reference

https://api.crossref.org/works/10.1042%2FCS20130043

21 January 2018

Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice

1 reference

https://api.crossref.org/works/10.1042%2FCS20130043

21 January 2018

Sensing damage by the NLRP3 inflammasome

1 reference

https://api.crossref.org/works/10.1042%2FCS20130043

21 January 2018

The NLRP3 inflammasome: a sensor for metabolic danger?

1 reference

https://api.crossref.org/works/10.1042%2FCS20130043

21 January 2018

NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production?

1 reference

https://api.crossref.org/works/10.1042%2FCS20130043

21 January 2018

The inflammasomes

1 reference

https://api.crossref.org/works/10.1042%2FCS20130043

21 January 2018

Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation

1 reference

https://api.crossref.org/works/10.1042%2FCS20130043

21 January 2018

NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder

1 reference

https://api.crossref.org/works/10.1042%2FCS20130043

21 January 2018

Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice: evidence for antiinflammatory effects of rosuvastatin

1 reference

https://api.crossref.org/works/10.1042%2FCS20130043

21 January 2018

Expression of let-7i is associated with Toll-like receptor 4 signal in coronary artery disease: effect of statins on let-7i and Toll-like receptor 4 signal

1 reference

https://api.crossref.org/works/10.1042%2FCS20130043

21 January 2018

MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression.

1 reference

https://api.crossref.org/works/10.1042%2FCS20130043

21 January 2018

Arachidonic acid metabolism by human monocytes. Studies with platelet-depleted cultures

1 reference

https://api.crossref.org/works/10.1042%2FCS20130043

21 January 2018

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1042%2FCS20130043

21 January 2018

Prediction of long-term functional outcome in patients with acute ischemic non-embolic stroke.

1 reference

https://api.crossref.org/works/10.1042%2FCS20130043

21 January 2018

Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1042%2FCS20130043

21 January 2018

The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance

1 reference

https://api.crossref.org/works/10.1042%2FCS20130043

21 January 2018

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

1 reference

https://api.crossref.org/works/10.1042%2FCS20130043

21 January 2018

Critical role of apoptotic speck protein containing a caspase recruitment domain (ASC) and NLRP3 in causing necrosis and ASC speck formation induced by Porphyromonas gingivalis in human cells.

1 reference

https://api.crossref.org/works/10.1042%2FCS20130043

21 January 2018

Active metabolite of atorvastatin inhibits membrane cholesterol domain formation by an antioxidant mechanism

1 reference

https://api.crossref.org/works/10.1042%2FCS20130043

21 January 2018

Effects of Obesity on Lipid-Lowering, Anti-Inflammatory, and Antiatherosclerotic Benefits of Atorvastatin or Pravastatin in Patients With Coronary Artery Disease (from the REVERSAL Study)

1 reference

https://api.crossref.org/works/10.1042%2FCS20130043

21 January 2018

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update

1 reference

https://api.crossref.org/works/10.1042%2FCS20130043

21 January 2018

Identifiers

10.1042/CS20130043

1 reference

Europe PubMed Central

9 September 2017

release_rcmn46lbkjdnpfmiwx2ahapjvq

1 reference

https://api.fatcat.wiki/v0/release/rcmn46lbkjdnpfmiwx2ahapjvq

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

9 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39110336&oldid=1839568810"